Phase 2 study of the g209-2M melanoma peptide vaccine and low-dose interleukin-2 in advanced melanoma: Cancer and Leukemia Group B 509901.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Cancer and Leukemia Group B John D. Roberts F Stephen Hodi |
| Publication date | January 1, 2006 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |